357 related articles for article (PubMed ID: 27153743)
1. Progestin-only contraception and thromboembolism: A systematic review.
Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
[TBL] [Abstract][Full Text] [Related]
2. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
3. Progestin-only contraceptives: effects on weight.
Lopez LM; Ramesh S; Chen M; Edelman A; Otterness C; Trussell J; Helmerhorst FM
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008815. PubMed ID: 27567593
[TBL] [Abstract][Full Text] [Related]
4. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
6. Progestin-only contraceptives: effects on weight.
Lopez LM; Edelman A; Chen M; Otterness C; Trussell J; Helmerhorst FM
Cochrane Database Syst Rev; 2013 Jul; 7(7):CD008815. PubMed ID: 23821307
[TBL] [Abstract][Full Text] [Related]
7. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
9. Safety of hormonal contraceptives among women with migraine: A systematic review.
Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
[TBL] [Abstract][Full Text] [Related]
10. Progestogen-only contraceptive use among breastfeeding women: a systematic review.
Phillips SJ; Tepper NK; Kapp N; Nanda K; Temmerman M; Curtis KM
Contraception; 2016 Sep; 94(3):226-52. PubMed ID: 26410174
[TBL] [Abstract][Full Text] [Related]
11. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Ramanadhan S; Hansen K; Henderson JT; Cohen MA; Paynter R; Edelman A
Cochrane Database Syst Rev; 2023 May; 5(5):CD014908. PubMed ID: 37184292
[TBL] [Abstract][Full Text] [Related]
12. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
13. Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.
Glisic M; Shahzad S; Tsoli S; Chadni M; Asllanaj E; Rojas LZ; Brown E; Chowdhury R; Muka T; Franco OH
Eur J Prev Cardiol; 2018 Jul; 25(10):1042-1052. PubMed ID: 29745237
[TBL] [Abstract][Full Text] [Related]
14. Progestin-only contraceptives: effects on weight.
Lopez LM; Edelman A; Chen-Mok M; Trussell J; Helmerhorst FM
Cochrane Database Syst Rev; 2011 Apr; (4):CD008815. PubMed ID: 21491411
[TBL] [Abstract][Full Text] [Related]
15. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cohen MA; Edelman A; Paynter R; Henderson JT
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
[TBL] [Abstract][Full Text] [Related]
16. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
Rott H
Hamostaseologie; 2019 Feb; 39(1):42-48. PubMed ID: 30669160
[TBL] [Abstract][Full Text] [Related]
17. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.
Mantha S; Karp R; Raghavan V; Terrin N; Bauer KA; Zwicker JI
BMJ; 2012 Aug; 345():e4944. PubMed ID: 22872710
[TBL] [Abstract][Full Text] [Related]
18. Superficial venous disease and combined hormonal contraceptives: a systematic review.
Tepper NK; Marchbanks PA; Curtis KM
Contraception; 2016 Sep; 94(3):275-9. PubMed ID: 25835269
[TBL] [Abstract][Full Text] [Related]
19. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
20. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Cockrum RH; Soo J; Ham SA; Cohen KS; Snow SG
Obstet Gynecol; 2022 Sep; 140(3):477-487. PubMed ID: 35926206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]